That doesn't suggest they don't seem to be contemplating it. Many breakthrough therapy designations have been granted for psilocybin from the treatment of resistant depression—that's, depression that does not respond to a minimum of two different types of antidepressants—plus a broader acceptance might be to the horizon.To put it simply, move i